» Articles » PMID: 23786195

Survival Time and Prognostic Factors in Cats with Newly Diagnosed Diabetes Mellitus: 114 Cases (2000-2009)

Overview
Date 2013 Jun 22
PMID 23786195
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine overall survival time and identify prognostic factors associated with survival time in cats with newly diagnosed diabetes mellitus.

Design: Retrospective case series.

Animals: 114 cats with newly diagnosed diabetes mellitus.

Procedures: Data for analysis included history, signalment, physical examination findings, hematologic and serum biochemical data, presence of ketoacidosis, and diagnosis of concurrent diseases at initial evaluation. The effects of possible predictors on survival time were determined by calculating hazard ratios (HRs) and 95% confidence intervals (CIs).

Results: Median survival time of diabetic cats was 516 days (range, 1 to 3,468 days); 70%, 64%, and 46% lived longer than 3, 6, and 24 months, respectively. Survival time was significantly shorter for cats with higher creatinine concentrations, with a hazard of dying approximately 5% greater for each increase of 10 μg/dL in serum creatinine concentration (adjusted HR, 1.005; 95% CI, 1.003 to 1.007). Ketoacidosis was not significantly associated with survival time (HR, 1.02; 95% CI, 0.590 to 1.78).

Conclusions And Clinical Relevance: Cats with newly diagnosed diabetes mellitus had a fair to good prognosis. High serum creatinine concentration at diagnosis was associated with a poor outcome, likely because of the adverse effects of renal dysfunction. Ketoacidosis apparently was not associated with decreased survival time, suggesting that this complication should not necessarily be regarded as unfavorable.

Citing Articles

Signalment and laboratory findings in cats with diabetes mellitus in Germany: a retrospective review of laboratory submissions of 129,505 cats.

Guse B, Langenstein J, Bauer N, Hazuchova K J Feline Med Surg. 2024; 26(9):1098612X241262669.

PMID: 39286966 PMC: 11418620. DOI: 10.1177/1098612X241262669.


Feline acute patient physiologic and laboratory evaluation scores and other prognostic factors in cats with first-time diabetic ketoacidosis.

Ad Y, Hess R J Vet Intern Med. 2024; 38(5):2425-2430.

PMID: 39115406 PMC: 11423431. DOI: 10.1111/jvim.17151.


SGLT2 inhibitor use in the management of feline diabetes mellitus.

Cook A, Behrend E J Vet Pharmacol Ther. 2024; 48 Suppl 1():19-30.

PMID: 38954371 PMC: 11736986. DOI: 10.1111/jvp.13466.


Frequency of diabetic remission, predictors of remission and survival in cats using a low-cost, moderate-intensity, home-monitoring protocol and twice-daily glargine.

Gottlieb S, Rand J, Anderson S J Feline Med Surg. 2024; 26(4):1098612X241232546.

PMID: 38661475 PMC: 11103314. DOI: 10.1177/1098612X241232546.


Survival, remission, and quality of life in diabetic cats.

Rothlin-Zachrisson N, Ohlund M, Rocklinsberg H, Holst B J Vet Intern Med. 2023; 37(1):58-69.

PMID: 36637031 PMC: 9889602. DOI: 10.1111/jvim.16625.